High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population

Journal of Human Genetics

Volumn 52, Issue 10, 2007, Pages 856-864

  Cha, Pei Chieng ^a   Mushiroda, Taisei ^b   Takahashi, Atsushi ^b   Saito, Shigeru ^c   Shimomura, Hideki ^c   Suzuki, Takao ^c   Kamatani, Naoyuki ^b   Nakamura, Yusuke ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c Tokushukai Group   (Japan)

Author keywords

Gamma glutamyl carboxylase; Inter individual differences; Single nucleotide polymorphism; Vitamin K dependent proteins; Warfarin

Indexed keywords

VITAMIN K GROUP; WARFARIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CARBOXYLATION; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; GAMMA GLUTAMYL CARBOXYLASE GENE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOEMBOLISM;

ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD COAGULATION; CARBON-CARBON LIGASES; CHROMOSOME MAPPING; FEMALE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; WARFARIN;

EID: 34848854159     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0183-9     Document Type: Article

References (25)

1. Chen LY, Eriksson N, Gwilliam R, Bentley D, Deloukas P, Wadelius M (2005) Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing. Blood 106(10):3673
2. Daly AK, King BP (2003) Pharmacogenetics of oral anticoagulants. Pharmacogenetics 13:247-252
3. - into prothrombin. JBC 250(12):4744-4748
4. FAO/WHO expert consultation on human vitamin and mineral requirements (1998) Chapter 6: Vitamin K. In: Vitamin and mineral requirements in human nutrition, 2nd edn. Report of a joint FAO/WHO expert consultation, Bangkok, Thailand. WHO Library Cataloguing-in-Publication Data, pp 108-129
5. Furie B, Furie BC (1988) The molecular basis of blood coagulation. Cell 53:505-518
6. Furie B, Furie BC (1990) Molecular basis of vitamin K-dependent γ-carboxylation. Blood 75:1753-1762
7. Herman D, Peternel P, Stegnar M, Breskvar K, Dolzan V (2006) The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement. Thromb Haemost 95:782-787
8. Horton JD, Bushwick BM (1999) Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 59(3):635-646
9. Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, Otsuki T, Okayama A, Minematsu K, Naritomi H, Honda S, Tomoike H, Miyata T (2007) Genotypes of vitamin K epoxide reductase, γ-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thrombosis Research 120(2):181-186
10. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N (2002) Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 66:183-193
11. Kuo W-L, Stafford DW, Cruces J, Gray J, Solera J (1995) Chromosomal localization of the gamma-glutamyl carboxylase gene at 2p12. Genomic 25:746-748
12. Li T, Chang C-Y, Jin D-Y, Lin P-J, Khvorova A, Stafford DW (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427:541-544
13. Loebstein R, Vecsler M, Kurnik D, Austerweil N, Gak E, Halkin H, Almog S (2005) Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9. Clin Pharmacol Ther 77(5):365-372
14. Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, Shimomura H, Wanibuchi Y, Suzuki T, Kamatani N, Nakamura Y (2006) Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet 51(3):249-253
15. Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745-2751
16. Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz H-J, Lappegard K, Seifried E, Scharrer I, Tuddenham EGD, Muller CR, Strom TM, Oldenburg J (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation fcator deficiency type 2. Nature 427:537-541
17. Schwartz UI, Stein CM (2006) Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants. Clin Pharmacol Ther 80(1):7-12
18. Shikata E, Ieiri I, Ishiguro S, Aono H, Inoue K, Koide T, Ohgi S, Otsubo K (2004) Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity. Blood 103(7):2630-2635
19. Slatkin M, Excoffier L (1996) Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 76:377-383
20. Suttie JW (1985) Vitamin K-dependent carboxylase. Ann Rev Biochem 54:459-77
21. Vecsler M, Loebstein R, Almog S, Kurnik D, Goldman B, Halkin H, Gak E (2006) Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin. Thromb Haemost 95:205-211
22. Wadelius M, Chen LY, Downew K, Ghori J, Hunt S, Eriksson N, Wallerman O, Melhus H, Wadelius C, Bentley D, Deloukas P (2005) Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J 5:262-270
23. Weir BS (1996) Genetic data analysis II: Methods for discrete population genetic data. Sinauer Associates, Inc., Canada
24. Wu S-M, Cheung W-F, Frazier D, Stafford DW (1991) Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 254:1634-1636
25. Wu S-M, Stafford DW, Frazier D, Fu Y-Y, High KA, Chu K, Sanchez-Vega B, Solera J (1997) Genomic sequence and transcription start site fot the human γ-glutamyl carboxylase. Blood 89(11):4058-4062